About Dr. Vikas Dua
Dr. Vikas Dua is a renowned consultant specializing in Pediatric Hemato-oncology and bone marrow transplants. With over 22 years of experience, he has conducted numerous successful Bone Marrow Transplants (BMTs) for thalassemia and leukemia cases, serving children from India, Afghanistan, Iraq, and African countries. Dr. Dua completed his MBBS & MD in Pediatrics from PGIMS, Rohtak, followed by a Fellowship in Diplomate of National Board (DNB) in Pediatrics from Sir Ganga Ram Hospital.
Dr. Dua pursued advanced training in Pediatric Bone Marrow Transplantation at the National University Hospital in Singapore and further honed his skills at St. Jude Children’s Research Hospital in Memphis, USA. He has received numerous national and international awards for his exceptional contributions to Pediatric BMT and is highly proficient in pediatric hematology and bone marrow transplantation.
Qualification
- MBBS, PGIMS, Rohtak
- MD, PGIMS, Rohtak
- FNB in Pediatric Hematology Oncology, Sir Ganga Ram Hospital
- Fellowship in Pediatric Bone Marrow Transplantation, Singapore
- Pediatric BMT, St. Jude Children’s Hospital, USA
Work Experience
- Senior Consultant, Fortis Memorial Research Institute, Gurgaon
- Consultant, Artemis Hospital, Gurgaon
- Consultant, Action Cancer Hospital, Delhi
Specialties
- Benign Pediatric Hematology
- Hemato-oncology
- Matched sibling and unrelated Pediatric haploidentical transplants
Award
Dr. Vikas Dua has published many articles in national and international journals of repute.
Treatment
- Bone Marrow Transplant
- Pediatric Bone Marrow Transplant
Similar Doctors
View All Top Doctors
Similar Hospitals
View All Top Hospitals
FAQ
A1: A bone marrow transplant (BMT) is a procedure to replace damaged or diseased bone marrow with healthy stem cells. It is often recommended for children with conditions such as leukemia, thalassemia, aplastic anemia, and certain genetic disorders.
A2: Bone marrow donors are matched with pediatric patients based on human leukocyte antigen (HLA) typing, which helps determine compatibility between the donor and recipient. Ideal matches are often found within the patient’s family members, but unrelated donors may also be identified through registries.
A3: Potential risks and complications of pediatric bone marrow transplantation include graft-versus-host disease, infections, bleeding, organ damage, and complications related to anesthesia. However, these risks are carefully managed by the medical team.
A4: The recovery period after a bone marrow transplant varies depending on factors such as the type of transplant, the underlying condition being treated, and the overall health of the child. Generally, it may take several weeks to months for the immune system to fully recover.
A5: In some cases, alternatives to bone marrow transplantation may include chemotherapy, targeted therapy, immunotherapy, and supportive care measures. The choice of treatment depends on the specific diagnosis and individual patient factors.
A6: Supportive care measures for pediatric patients undergoing bone marrow transplantation may include antibiotics to prevent infections, blood transfusions to manage anemia, medications to prevent graft-versus-host disease, and nutritional support to maintain overall health and well-being.
